--- title: "Imprimis NJOF, LLC Recalls: Agency-Reported Status and History (Oct 1, 2026) | Is It on Recall" description: "Search Imprimis NJOF, LLC recall records, lots, firms and dates. Reported status can be incomplete; use the linked agency notice for current instructions." url: https://isitonrecall.com/brand/imprimis-njof-llc/ updated: 2026-10-01 site: "Is It on Recall" language: en --- [Home](https://isitonrecall.com/) / Brand archive # Imprimis NJOF, LLC recall records **15** reported ongoing 20 records in this archive. Latest source date Dec 18, 2025. FDA enforcement status can lag behind the recall lifecycle. An empty search or a reported termination is not a personal product-safety determination. Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/). ## Records and reported status Dec 18, 2025 FDA drug enforcement ### [Dexamethasone Moxifloxacin, 1 mg/mL and 5 mg/mL, 1 mL Intraocular Injection, Rx only, Imprimis NJOF, LLC, Ledgewood, NJ 07852, NDC 71384-512-0.1](https://isitonrecall.com/recall/fda-drug-d-0249-2026-dexamethasone-moxifloxacin-1-mg-ml-and-5-mg-ml-1-ml-intraocular-injection-rx-only-imprimis-njof-llc/) Presence of particulate matter - Glass like particles. Class II Reported ongoing Distribution: U.S Nationwide [Official source for Dexamethasone Moxifloxacin, 1 mg/mL and 5 mg/mL, 1 mL Intraocular Injection, Rx only, Imprimis NJ...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0249-2026%22) Dec 18, 2025 FDA drug enforcement ### [Dexamethasone Moxifloxacin Ketorolac, 1 mg/mL, 0.5 mg/mL, 0.4 mg/mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852, NDC...](https://isitonrecall.com/recall/fda-drug-d-0250-2026-dexamethasone-moxifloxacin-ketorolac-1-mg-ml-0-5-mg-ml-0-4-mg-ml-single-use-intraocular-injection-im/) Presence of particulate matter - Glass like particles. Class II Reported ongoing Distribution: U.S Nationwide [Official source for Dexamethasone Moxifloxacin Ketorolac, 1 mg/mL, 0.5 mg/mL, 0.4 mg/mL) Single-Use Intraocular Injec...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0250-2026%22) Dec 18, 2025 FDA drug enforcement ### [Tri-Moxi+¿ (Triamcinolone 9mg/0.6mL, Moxifloxacin 0.6 mg/ 0.6 mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852. NDC 71...](https://isitonrecall.com/recall/fda-drug-d-0251-2026-tri-moxi-triamcinolone-9mg-0-6ml-moxifloxacin-0-6-mg-0-6-ml-single-use-intraocular-injection-imprimi/) Presence of particulate matter - Glass like particles. Class II Reported ongoing Distribution: U.S Nationwide [Official source for Tri-Moxi+¿ (Triamcinolone 9mg/0.6mL, Moxifloxacin 0.6 mg/ 0.6 mL) Single-Use Intraocular Injectio...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0251-2026%22) Oct 20, 2025 FDA drug enforcement ### [Klarity-C Drops (Cyclosporine) 0.1%, Preservative-Free Sterile Ophthalmic Emulsion, This is a compounded drug, Office Use Only, 5.5 mL bottle, Rx only, Mfg by: Imprimis NJOF, LL...](https://isitonrecall.com/recall/fda-drug-d-0157-2026-klarity-c-drops-cyclosporine-0-1-preservative-free-sterile-ophthalmic-emulsion-this-is-a-compounded/) Subpotent Drug Class III Reported ongoing Distribution: USA nationwide [Official source for Klarity-C Drops (Cyclosporine) 0.1%, Preservative-Free Sterile Ophthalmic Emulsion, This is a com...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0157-2026%22) Jul 9, 2025 FDA drug enforcement ### [Epinephrine Lidocaine HCL, 0.25mg/mL and 7.5 mg/mL, 20x1 mL Vials per carton, Rx Only, Imprimis NJOF, 1705 Route 46 West, Unit 6B Ledgewood, NJ, 07852 NDC: 71384-641-01](https://isitonrecall.com/recall/fda-drug-d-0535-2025-epinephrine-lidocaine-hcl-0-25mg-ml-and-7-5-mg-ml-20x1-ml-vials-per-carton-rx-only-imprimis-njof-170/) Sub-Potent Drug: Subpotent assay results during stability testing. Class II Reported completed Distribution: Nationwide in the USA [Official source for Epinephrine Lidocaine HCL, 0.25mg/mL and 7.5 mg/mL, 20x1 mL Vials per carton, Rx Only, Imprimis N...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0535-2025%22) Jul 9, 2025 FDA drug enforcement ### [Tropicamide-Proparacaine-Phenylephrine-Ketorolac, Sterile Ophthalmic Solution, 1% 0.5% 2.5% 0.5%, 5mL, 2x5ML vial per carton, Rx Only, Imprimis NJOF, LLC, 1705 Route 46 West, Un...](https://isitonrecall.com/recall/fda-drug-d-0536-2025-tropicamide-proparacaine-phenylephrine-ketorolac-sterile-ophthalmic-solution-1-0-5-2-5-0-5-5ml-2x5ml/) Sub-Potent Drug: Subpotent assay results during stability testing. Class III Reported completed Distribution: Nationwide in the USA [Official source for Tropicamide-Proparacaine-Phenylephrine-Ketorolac, Sterile Ophthalmic Solution, 1% 0.5% 2.5% 0.5%,...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0536-2025%22) Feb 24, 2025 FDA drug enforcement ### [Tropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic Solution, 1% 0.5% 2.5% 0.5%, 5 mL fill in 15 mL bottle, Imprimis NJOF, LLC, Route 46 West, Unit 6B, Led...](https://isitonrecall.com/recall/fda-drug-d-0305-2025-tropicamide-proparacaine-phenylephrine-ketorolac-sterile-ophthalmic-solution-1-0-5-2-5-0-5-5-ml-fill/) Sub-Potent Drug: The stability batch showed a subpotent result, which does not meet the product specifications of 90.0-110.0% of the label claim. Class III Reported ongoing Distribution: FL and NY [Official source for Tropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic Solution, 1% 0.5% 2.5% ...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0305-2025%22) May 14, 2024 FDA drug enforcement ### [Epinephrine-Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL Preservative-Free 1mL Single-Use vials for Intraocular Injection, Imprimis NJOF, LLC. 1705 Route 46 West, unit 6B, Ledgewood, ...](https://isitonrecall.com/recall/fda-drug-d-0512-2024-epinephrine-lidocaine-hcl-0-25-mg-ml-and-7-5-mg-ml-preservative-free-1ml-single-use-vials-for-intrao/) Lack of Assurance of Sterility Class II Reported ongoing Distribution: Nationwide within the United States [Official source for Epinephrine-Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL Preservative-Free 1mL Single-Use vials for Int...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0512-2024%22) May 14, 2024 FDA drug enforcement ### [Dexamethasone-Moxifloxacin (1 mg/mL and 5mg/mL) Preservative-Free, 1mL Single-Use vials for Intraocular Injection, Rx only, Imprimis NJOF, LLC. 1705 Route 46 West, unit 6B, Ledg...](https://isitonrecall.com/recall/fda-drug-d-0513-2024-dexamethasone-moxifloxacin-1-mg-ml-and-5mg-ml-preservative-free-1ml-single-use-vials-for-intraocular/) Lack of Assurance of Sterility Class II Reported ongoing Distribution: Nationwide within the United States [Official source for Dexamethasone-Moxifloxacin (1 mg/mL and 5mg/mL) Preservative-Free, 1mL Single-Use vials for Intra...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0513-2024%22) May 14, 2024 FDA drug enforcement ### [Dexamethasone-Moxifloxacin- Ketorolac (1mg/mL, 0.5 mg/mL and 0.4 mg/mL), Preservative-Free, 1mL Single-Use vials for Intraocular Injection, Rx only, Imprimis NJOF, LLC. 1705 Rou...](https://isitonrecall.com/recall/fda-drug-d-0514-2024-dexamethasone-moxifloxacin-ketorolac-1mg-ml-0-5-mg-ml-and-0-4-mg-ml-preservative-free-1ml-single-use/) Lack of Assurance of Sterility Class II Reported ongoing Distribution: Nationwide within the United States [Official source for Dexamethasone-Moxifloxacin- Ketorolac (1mg/mL, 0.5 mg/mL and 0.4 mg/mL), Preservative-Free, 1mL S...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0514-2024%22) May 14, 2024 FDA drug enforcement ### [Moxifloxacin 0.8 mg/0.8 mL Preservative-Free 0.8mL Single-Use vials for Intraocular Injection, Rx only, Imprimis NJOF, LLC. 1705 Route 46 West, unit 6B, Ledgewood, NJ 07852, NDC...](https://isitonrecall.com/recall/fda-drug-d-0515-2024-moxifloxacin-0-8-mg-0-8-ml-preservative-free-0-8ml-single-use-vials-for-intraocular-injection-rx-onl/) Lack of Assurance of Sterility Class II Reported ongoing Distribution: Nationwide within the United States [Official source for Moxifloxacin 0.8 mg/0.8 mL Preservative-Free 0.8mL Single-Use vials for Intraocular Injection, Rx...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0515-2024%22) May 14, 2024 FDA drug enforcement ### [Moxifloxacin 4 mg/0.8 mL Preservative-Free 0.8mL Single-Use vials for Intraocular Injection, Rx only, Imprimis NJOF, LLC. 1705 Route 46 West, unit 6B, Ledgewood, NJ 07852, NDC 7...](https://isitonrecall.com/recall/fda-drug-d-0516-2024-moxifloxacin-4-mg-0-8-ml-preservative-free-0-8ml-single-use-vials-for-intraocular-injection-rx-only/) Lack of Assurance of Sterility Class II Reported ongoing Distribution: Nationwide within the United States [Official source for Moxifloxacin 4 mg/0.8 mL Preservative-Free 0.8mL Single-Use vials for Intraocular Injection, Rx o...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0516-2024%22) May 14, 2024 FDA drug enforcement ### [Epinephrine-Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL Preservative-Free 1mL Single-Use vial for Intraocular Injection, Imprimis NJOF, LLC. 1705 Route 46 West, unit 6B, Ledgewood, N...](https://isitonrecall.com/recall/fda-drug-d-0519-2024-epinephrine-lidocaine-hcl-0-25-mg-ml-and-7-5-mg-ml-preservative-free-1ml-single-use-vial-for-intraoc/) Lack of Assurance of Sterility Class II Reported ongoing Distribution: Nationwide within the United States [Official source for Epinephrine-Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL Preservative-Free 1mL Single-Use vial for Intr...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0519-2024%22) May 14, 2024 FDA drug enforcement ### [Klarity-C (cyclosporine) Preservative-Free Sterile Ophthalmic Emulsion 0.1% 5.5mL, Rx Only, This is a compounded drug. NOT FOR RESALE. OFFICE USE ONLY Compounded by: Imprimis NJ...](https://isitonrecall.com/recall/fda-drug-d-0547-2024-klarity-c-cyclosporine-preservative-free-sterile-ophthalmic-emulsion-0-1-5-5ml-rx-only-this-is-a-com/) Lack of Assurance of Sterility Class II Reported ongoing Distribution: US Nationwide [Official source for Klarity-C (cyclosporine) Preservative-Free Sterile Ophthalmic Emulsion 0.1% 5.5mL, Rx Only, This ...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0547-2024%22) May 14, 2024 FDA drug enforcement ### [Prednisolone-Moxifloxacin-Bromfenac Sterile Ophthalmic Suspension, 1%, 0.5%, 0.075%, 5mL, Quantity: 20mL, Rx Only, Compounded by: Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B...](https://isitonrecall.com/recall/fda-drug-d-0548-2024-prednisolone-moxifloxacin-bromfenac-sterile-ophthalmic-suspension-1-0-5-0-075-5ml-quantity-20ml-rx-o/) Lack of Assurance of Sterility Class II Reported ongoing Distribution: US Nationwide [Official source for Prednisolone-Moxifloxacin-Bromfenac Sterile Ophthalmic Suspension, 1%, 0.5%, 0.075%, 5mL, Quantit...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0548-2024%22) Apr 10, 2024 FDA drug enforcement ### [Prednisolone Sodium Phosphate-Moxifloxacin-Bromfenac Sterile Ophthalmic Solution 1%, 0.5%, 0.075%, 8mL, Compounded By: Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B Ledgewood,...](https://isitonrecall.com/recall/fda-drug-d-0476-2024-prednisolone-sodium-phosphate-moxifloxacin-bromfenac-sterile-ophthalmic-solution-1-0-5-0-075-8ml-com/) Subpotent Drug Class II Reported ongoing Distribution: U.S. Nationwide [Official source for Prednisolone Sodium Phosphate-Moxifloxacin-Bromfenac Sterile Ophthalmic Solution 1%, 0.5%, 0.075%...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0476-2024%22) Apr 10, 2024 FDA drug enforcement ### [Epinephrine-Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL Preservative-Free, 1 mL Single-Use vials, Rx only, Imprimis NJOF, LLC 1705 Route 46 West, Unit 6B, Ledgewood, NJ, 07852, NDC 7...](https://isitonrecall.com/recall/fda-drug-d-0478-2024-epinephrine-lidocaine-hcl-0-25-mg-ml-and-7-5-mg-ml-preservative-free-1-ml-single-use-vials-rx-only-i/) Out of specification for assay Class III Reported ongoing Distribution: Nationwide within the United States [Official source for Epinephrine-Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL Preservative-Free, 1 mL Single-Use vials, Rx o...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0478-2024%22) Oct 3, 2023 FDA drug enforcement ### [Epinephrine-Lidocaine HCl (0.25mg/mL and 7.5mg/mL) 1mL Single Use Intraocular injection Preservative Free NDC 71384-640-01 Not for resale. Office use only. Lot: 23APR018 Date Co...](https://isitonrecall.com/recall/fda-drug-d-0040-2024-epinephrine-lidocaine-hcl-0-25mg-ml-and-7-5mg-ml-1ml-single-use-intraocular-injection-preservative-f/) Subpotent: Failing Test Results for Epinephrine Class III Reported terminated Distribution: Nationwide [Official source for Epinephrine-Lidocaine HCl (0.25mg/mL and 7.5mg/mL) 1mL Single Use Intraocular injection Preservat...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0040-2024%22) Sep 20, 2023 FDA drug enforcement ### [MYDRIATIC-4: Tropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic Solution Drops 1% - 0.5% - 2.5% - 0.5%, 5mL bottle, Imprimis, NJOF, 1705 Route 46 West, Un...](https://isitonrecall.com/recall/fda-drug-d-0043-2024-mydriatic-4-tropicamide-proparacaine-phenylephrine-ketorolac-sterile-ophthalmic-solution-drops-1-0-5/) Subpotent: Out of Specification result observed for Ketorolac assay levels, below the 90.0-110.0% of label claim. Class III Reported terminated Distribution: Product was distributed to physician's offices nationwide. [Official source for MYDRIATIC-4: Tropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic Solution D...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0043-2024%22) Aug 10, 2023 FDA drug enforcement ### [Moxifloxacin - Bromfenac Sterile Ophthalmic Solution 0.5% / 0.075%, 5mL bottle, Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852 (844)-446-6979, NDC: 71384-3...](https://isitonrecall.com/recall/fda-drug-d-1094-2023-moxifloxacin-bromfenac-sterile-ophthalmic-solution-0-5-0-075-5ml-bottle-imprimis-njof-llc-1705-route/) Subpotent Drug; sub-potent Bromfenac levels, below the 90.0-110.0% specification range. Class III Reported terminated Distribution: Nationwide in the US [Official source for Moxifloxacin - Bromfenac Sterile Ophthalmic Solution 0.5% / 0.075%, 5mL bottle, Imprimis NJOF, LL...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-1094-2023%22) ## Reasons in these listed records - Presence of particulate matter - Glass like particles. - Subpotent Drug - Sub-Potent Drug: Subpotent assay results during stability testing. - Sub-Potent Drug: The stability batch showed a subpotent result, which does not meet the product specifications of 90.0-110.0% of the label claim. These examples come from this result page and are not a ranking of every recall reason. ## Checking Imprimis NJOF, LLC ### Is there a recall on imprimis njof, llc right now? This archive contains 20 records, including 15 with agency-reported ongoing status. The status field can be incomplete or stale. Open the current official notice and match your exact product. ### How do I check my package or product? Compare the product, firm and lot, date, model or serial identifiers with the notice. [Use the label-check guide](https://isitonrecall.com/guides/read-lot-codes/) if you need help locating an identifier. ### Does a matching name mean every item is included? A name is a search match. The agency notice sets the affected products and identifiers. Do not assume that every item with the same name or brand belongs to the recall. ### What if the search finds no matching record? This search has source and keyword limits. Missing records or a missing lot code do not establish that a product is unaffected. [Check source coverage](https://isitonrecall.com/sources/) and the agency's current notices. ### Where can I find older records? Use [monthly archives](https://isitonrecall.com/archives/) or the local search. The initial import covers records dated from October 2021 where available; each source's actual first and latest dates appear on the coverage page. ## Keep checking [Search Imprimis NJOF, LLC](https://isitonrecall.com/check/?q=Imprimis%20NJOF%2C%20LLC) [Browse related products](https://isitonrecall.com/products/) [Review source dates](https://isitonrecall.com/sources/)